Welcome!

News Feed Item

The 15th Annual BioEquity Europe Conference Features More Than 100 Innovator Companies With Differentiated Products, Upcoming Milestones and Partner-Ready Assets

Two Days of Plenary Sessions Examine How European Companies Are Stepping Up to Play in Biotech's Premier League

REDWOOD CITY, CA -- (Marketwired) -- 05/20/14 -- BioCentury, EBD Group and the Biotechnology Industry Organization (BIO) will convene the 15th Annual BioEquity Europe conference in Amsterdam on Wednesday, May 21, and Thursday, May 22, at the Hilton Amsterdam Hotel. More than 500 life science investment professionals and pharmaceutical business development and licensing executives have registered. Walk-up registration is available at the Hilton Amsterdam Hotel starting at 7:45 a.m. on May 21.

BioEquity Europe is the seminal industry event for financial dealmakers looking for investor-validated life science companies positioning themselves to attract capital, and for pharmaceutical licensing professionals to assess top prospects.

In 2014, the conference will showcase presentations by 68 mature and 42 newly formed innovator biopharma companies. The Presenting Companies have been hand-picked by BioCentury on the basis of investor validation, upcoming milestones and unpartnered assets. The slate of Next Wave Companies features fresh opportunities for venture capital investment and early stage partnering opportunities in the biotech space.

More than half a dozen plenaries and Q&A sessions over the two days will feature 45 key opinion leaders. These sessions will be highlighted by a fireside chat with Dr. Jordi Llinares-Garcia -- EMA's Head of Product Development Scientific Support Department and former Head of Orphan Drugs. During this session, BioCentury's Chairman & Editor-in-Chief Dr. Karen Bernstein will interview Dr. Llinares-Garcia about how the agency acts as an "enabler" for smaller players, including academia, in the pharmaceutical innovation ecosystem.

Back by popular demand is the BioCentury/Ernst & Young Face-Off. At the Face-Off, BioCentury will unveil its 12th annual "European Iceberg" report, which projects funding demands by Europe's clinical stage biotechnology companies, and Ernst & Young will provide analysis from its 28th annual "Beyond Borders Global Biotechnology Report." The Face-Off will be chaired by Susan Schaeffer, Editor of BioCentury, and Jürg Zürcher, Partner, EMEIA Biotechnology Leader, Ernst & Young.

Other plenaries will focus on how European biotechs can better compete with U.S. companies for capital, and how European science stands up against a global playing field.

"The full slate of presenting companies, distinguished faculty and strong pre-registration numbers indicate a renewed interest in European biotechs by the investment and licensing communities," said BioCentury Publisher Eric Pierce. "The compelling stories from the Class of 2014, coupled with high-impact discussions with our international faculty, make BioEquity Europe a must-attend event for investors and business development and licensing professionals."

See the complete program, including presenting companies, plenary schedules and a list of the 2014 faculty at http://www.biocentury.com/conferences/bioequityeurope/dates/schedule.

The 2014 BioEquity Europe Presenting Companies
Presenting companies were screened using BioCentury's industry analysis and proprietary databases, including BioCentury's BCIQ online business intelligence platform. The result is an independently selected mix of companies with proven fundraising ability, prospects for key partnerships and proximity to potentially transformational milestones.

View the complete list of presenting companies and Next Wave Presenting Companies at http://www.biocentury.com/conferences/bioequityeurope/companies/presentingcompanies.

The BioEquity Europe Sponsors & Regional Host Committee
This unique turf-neutral setting is made possible by the support of the region's life science organizations and BioEquity Europe's Sponsors. The Regional Host Committee is comprised of Amsterdam BioMed Cluster/Amsterdam Economic Board, Axon, Deloitte and Van Campen Liem.

The prestigious group of 2014 sponsors is anchored by Gold Sponsors Ernst & Young, MS Ventures and Sofinnova Partners and Silver Sponsors Abingworth, AstraZeneca, Boehringer Ingelheim Venture Fund, Edwards Wildman, Geller Biopharm, Gilde Healthcare, Index Ventures, Inserm Transfert Initiative, Johnson & Johnson Innovation, LSP-Life Sciences Partners, Oxford Finance, Piper Jaffray and Roche Venture Fund.

About BioCentury
Since 1993, BioCentury Publications, Inc. has provided essential biopharma industry intelligence to a global audience of biotech and pharmaceutical executives, investors, regulators and public policy makers, and the scientific community. This audience has benefited from BioCentury's deep knowledge, data-driven analysis, independent perspective and trustworthy content available through the company's publications, television, data products and collaborative industry conferences in the U.S., Europe and Asia.

BioEquity Europe is one of three annual investor conferences organized by BioCentury. The next conference, NewsMakers in the Biotech Industry, will take place on Sept. 26, 2014, followed by Future Leaders in the Biotech Industry, on March 20, 2015. Both events will take place at the Millennium Broadway Hotel & Conference Center in New York City.

For more information, visit www.biocentury.com and www.biocenturytv.com.

About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group's partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.

EBD Group's conferences are run with the support of leading corporations and international trade associations and include:

  • BIO-Europe® and BIO-Europe Spring®, supported by the Biotechnology Industry Organization (BIO)
  • BioPharm America™
  • Biotech Showcase™, co-produced with Demy-Colton Life Science Advisors
  • BioEquity Europe, co-organized with BioCentury Publications and BIO
  • ChinaBio® Partnering Forum, co-produced with ChinaBio® LLC
  • EuroMedtech™
  • Partnering for Global Impact®

EBD Group's sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.

EBD Group is an Informa company. Informa is the largest publicly owned organizer of exhibitions, conferences and training in the world.

EBD Group has offices in the USA and Europe.

About the Biotechnology Industry Organization
BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the U.S. and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
Kubernetes is a new and revolutionary open-sourced system for managing containers across multiple hosts in a cluster. Ansible is a simple IT automation tool for just about any requirement for reproducible environments. In his session at @DevOpsSummit at 18th Cloud Expo, Patrick Galbraith, a principal engineer at HPE, discussed how to build a fully functional Kubernetes cluster on a number of virtual machines or bare-metal hosts. Also included will be a brief demonstration of running a Galera MyS...
It is of utmost importance for the future success of WebRTC to ensure that interoperability is operational between web browsers and any WebRTC-compliant client. To be guaranteed as operational and effective, interoperability must be tested extensively by establishing WebRTC data and media connections between different web browsers running on different devices and operating systems. In his session at WebRTC Summit at @ThingsExpo, Dr. Alex Gouaillard, CEO and Founder of CoSMo Software, presented ...
Enterprises are universally struggling to understand where the new tools and methodologies of DevOps fit into their organizations, and are universally making the same mistakes. These mistakes are not unavoidable, and in fact, avoiding them gifts an organization with sustained competitive advantage, just like it did for Japanese Manufacturing Post WWII.
DXWorldEXPO LLC, the producer of the world's most influential technology conferences and trade shows has announced the 22nd International CloudEXPO | DXWorldEXPO "Early Bird Registration" is now open. Register for Full Conference "Gold Pass" ▸ Here (Expo Hall ▸ Here)
In his session at @DevOpsSummit at 20th Cloud Expo, Kelly Looney, director of DevOps consulting for Skytap, showed how an incremental approach to introducing containers into complex, distributed applications results in modernization with less risk and more reward. He also shared the story of how Skytap used Docker to get out of the business of managing infrastructure, and into the business of delivering innovation and business value. Attendees learned how up-front planning allows for a clean sep...
Amazon started as an online bookseller 20 years ago. Since then, it has evolved into a technology juggernaut that has disrupted multiple markets and industries and touches many aspects of our lives. It is a relentless technology and business model innovator driving disruption throughout numerous ecosystems. Amazon’s AWS revenues alone are approaching $16B a year making it one of the largest IT companies in the world. With dominant offerings in Cloud, IoT, eCommerce, Big Data, AI, Digital Assista...
"Our strategy is to focus on the hyperscale providers - AWS, Azure, and Google. Over the last year we saw that a lot of developers need to learn how to do their job in the cloud and we see this DevOps movement that we are catering to with our content," stated Alessandro Fasan, Head of Global Sales at Cloud Academy, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
Recently, REAN Cloud built a digital concierge for a North Carolina hospital that had observed that most patient call button questions were repetitive. In addition, the paper-based process used to measure patient health metrics was laborious, not in real-time and sometimes error-prone. In their session at 21st Cloud Expo, Sean Finnerty, Executive Director, Practice Lead, Health Care & Life Science at REAN Cloud, and Dr. S.P.T. Krishnan, Principal Architect at REAN Cloud, discussed how they built...
"I focus on what we are calling CAST Highlight, which is our SaaS application portfolio analysis tool. It is an extremely lightweight tool that can integrate with pretty much any build process right now," explained Andrew Siegmund, Application Migration Specialist for CAST, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
As ridesharing competitors and enhanced services increase, notable changes are occurring in the transportation model. Despite the cost-effective means and flexibility of ridesharing, both drivers and users will need to be aware of the connected environment and how it will impact the ridesharing experience. In his session at @ThingsExpo, Timothy Evavold, Executive Director Automotive at Covisint, discussed key challenges and solutions to powering a ride sharing and/or multimodal model in the age ...
When shopping for a new data processing platform for IoT solutions, many development teams want to be able to test-drive options before making a choice. Yet when evaluating an IoT solution, it’s simply not feasible to do so at scale with physical devices. Building a sensor simulator is the next best choice; however, generating a realistic simulation at very high TPS with ease of configurability is a formidable challenge. When dealing with multiple application or transport protocols, you would be...
As organizations shift towards IT-as-a-service models, the need for managing and protecting data residing across physical, virtual, and now cloud environments grows with it. Commvault can ensure protection, access and E-Discovery of your data – whether in a private cloud, a Service Provider delivered public cloud, or a hybrid cloud environment – across the heterogeneous enterprise. In his general session at 18th Cloud Expo, Randy De Meno, Chief Technologist - Windows Products and Microsoft Part...
"Venafi has a platform that allows you to manage, centralize and automate the complete life cycle of keys and certificates within the organization," explained Gina Osmond, Sr. Field Marketing Manager at Venafi, in this SYS-CON.tv interview at DevOps at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
In IT, we sometimes coin terms for things before we know exactly what they are and how they’ll be used. The resulting terms may capture a common set of aspirations and goals – as “cloud” did broadly for on-demand, self-service, and flexible computing. But such a term can also lump together diverse and even competing practices, technologies, and priorities to the point where important distinctions are glossed over and lost.
Data is the fuel that drives the machine learning algorithmic engines and ultimately provides the business value. In his session at Cloud Expo, Ed Featherston, a director and senior enterprise architect at Collaborative Consulting, discussed the key considerations around quality, volume, timeliness, and pedigree that must be dealt with in order to properly fuel that engine.